PARP Inhibitors for BRCA1/2-mutated and Sporadic Ovarian Cancer: Current Practice and Future Directions

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2016.311
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC